Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting the results of antimalarial efficacy studies.|
|Full bibliographic reference||Plucinski MM, Ashley EA, Bassat Q, Venkatesan M, Rosenthal PJ, Halsey ES. STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting.
This guideline was published simultaneously in 2 journals. You can read the guideline in either of these journals using the links below.
Am J Trop Med Hyg. 2022;107(1):1-3. PMID: 35880678
Malar J. 2022 Jun 13;21(1):187. PMID: 35698123
|Reporting guideline acronym||STARTER|
|Study design||Clinical trials, Experimental studies|
|Clinical area||Infectious diseases, Tropical medicine|
|Applies to the whole report or to individual sections of the report?||Data, Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.)|
|Record last updated on||November 3, 2022|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.